Therapeutic implications of the use of selective beta‐adrenoceptor antagonists in clinical cardiology — A current review

AbstractDuring the last five years of the beta‐blocker era, there has been a slow but steadily increasing interest in the clinical aspects of the selective compounds. A critical appraisal of the works published in the various fields of angina, hypertension, metabolic disorders, respiratory function, stress and exercise responses, suggests a therapeutic progress worthy of the clinician's attention.